Nifty
Sensex
:
:
11796.45
39434.94
96.80 (0.83%)
311.98 (0.80%)

Pharmaceuticals & Drugs

Rating :
47/99

BSE: 524558 | NSE: NEULANDLAB

549.35
30.15 (5.81%)
25-Jun-2019 | 3:49PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  517.00
  •  555.00
  •  515.20
  •  519.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  26857
  •  147.54
  •  827.30
  •  425.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 663.50
  • 41.10
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 857.11
  • 0.23%
  • 0.96

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.90%
  • 0.00%
  • 19.97%
  • FII
  • DII
  • Others
  • 0.03%
  • 6.01%
  • 38.09%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.13
  • 7.29
  • 4.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.36
  • -2.70
  • -11.35

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 0.45
  • -29.66

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.90
  • 30.92
  • 42.75

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.41
  • 3.20
  • 3.36

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.13
  • 12.96
  • 15.75

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
666.83
527.41
578.89
509.97
469.15
465.69
460.59
448.50
396.91
278.42
Net Sales Growth
-
26.43%
-8.89%
13.51%
8.70%
0.74%
1.11%
2.70%
13.00%
42.56%
 
Cost Of Goods Sold
-
366.24
238.37
262.90
253.46
243.99
246.53
269.20
284.69
249.90
161.99
Gross Profit
-
300.59
289.04
315.99
256.52
225.16
219.16
191.39
163.81
147.01
116.44
GP Margin
-
45.08%
54.80%
54.59%
50.30%
47.99%
47.06%
41.55%
36.52%
37.04%
41.82%
Total Expenditure
-
608.46
476.98
472.55
429.52
402.53
395.08
402.91
401.69
349.65
254.63
Power & Fuel Cost
-
26.81
25.95
25.78
22.24
22.53
18.31
18.97
15.84
13.62
10.60
% Of Sales
-
4.02%
4.92%
4.45%
4.36%
4.80%
3.93%
4.12%
3.53%
3.43%
3.81%
Employee Cost
-
110.46
102.99
92.74
65.38
51.81
41.74
40.75
35.92
29.73
24.52
% Of Sales
-
16.56%
19.53%
16.02%
12.82%
11.04%
8.96%
8.85%
8.01%
7.49%
8.81%
Manufacturing Exp.
-
50.10
55.54
44.90
39.31
43.56
40.98
35.86
33.76
29.98
29.36
% Of Sales
-
7.51%
10.53%
7.76%
7.71%
9.28%
8.80%
7.79%
7.53%
7.55%
10.55%
General & Admin Exp.
-
27.49
33.32
28.30
29.72
23.59
15.95
16.27
14.27
14.29
16.95
% Of Sales
-
4.12%
6.32%
4.89%
5.83%
5.03%
3.43%
3.53%
3.18%
3.60%
6.09%
Selling & Distn. Exp.
-
18.28
14.04
11.16
17.52
14.54
26.57
13.51
11.42
10.80
8.08
% Of Sales
-
2.74%
2.66%
1.93%
3.44%
3.10%
5.71%
2.93%
2.55%
2.72%
2.90%
Miscellaneous Exp.
-
9.08
6.77
6.78
1.89
2.52
4.99
8.35
5.79
1.32
8.08
% Of Sales
-
1.36%
1.28%
1.17%
0.37%
0.54%
1.07%
1.81%
1.29%
0.33%
1.13%
EBITDA
-
58.37
50.43
106.34
80.45
66.62
70.61
57.68
46.81
47.26
23.79
EBITDA Margin
-
8.75%
9.56%
18.37%
15.78%
14.20%
15.16%
12.52%
10.44%
11.91%
8.54%
Other Income
-
3.49
4.53
1.17
1.78
0.78
3.44
4.06
2.19
2.90
5.63
Interest
-
15.66
18.93
21.09
24.48
27.36
24.56
31.33
33.27
29.84
25.67
Depreciation
-
25.86
22.10
19.23
15.74
15.32
14.94
14.62
14.89
15.41
13.56
PBT
-
20.34
13.93
67.19
42.00
24.72
34.55
15.78
0.83
4.92
-9.81
Tax
-
3.90
1.87
20.32
14.92
8.79
7.80
1.96
-1.74
-0.35
-2.89
Tax Rate
-
19.17%
13.42%
30.24%
35.52%
35.56%
22.58%
12.42%
-209.64%
-7.11%
29.46%
PAT
-
16.44
12.06
46.86
27.33
15.94
26.80
13.86
2.56
5.29
-6.90
PAT before Minority Interest
-
16.44
12.06
46.86
27.08
15.93
26.75
13.82
2.57
5.27
-6.92
Minority Interest
-
0.00
0.00
0.00
0.25
0.01
0.05
0.04
-0.01
0.02
0.02
PAT Margin
-
2.47%
2.29%
8.09%
5.36%
3.40%
5.75%
3.01%
0.57%
1.33%
-2.48%
PAT Growth
-
36.32%
-74.26%
71.46%
71.46%
-40.52%
93.36%
441.41%
-51.61%
-
 
Unadjusted EPS
-
13.06
10.81
42.01
30.76
18.67
32.33
18.14
4.24
9.76
-12.83

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
699.31
558.04
545.62
186.63
161.38
123.99
99.83
76.12
73.62
68.41
Share Capital
12.90
8.95
8.95
8.95
8.95
7.73
7.72
5.47
5.47
5.47
Total Reserves
686.41
238.24
225.81
177.68
152.42
116.26
92.12
70.63
68.15
62.95
Non-Current Liabilities
104.06
146.43
54.37
69.42
54.76
52.33
61.85
58.90
74.25
233.18
Secured Loans
60.72
103.49
29.81
33.40
21.22
8.87
26.11
55.90
71.58
233.18
Unsecured Loans
0.00
0.00
0.00
12.00
12.00
25.00
25.00
0.00
0.00
0.00
Long Term Provisions
11.91
9.87
9.28
6.85
6.38
5.14
4.71
3.85
2.67
0.00
Current Liabilities
326.98
366.93
285.60
268.00
295.14
306.90
262.99
288.53
279.71
96.16
Trade Payables
122.29
124.29
85.92
83.86
111.81
93.94
82.02
110.85
104.49
72.11
Other Current Liabilities
54.84
41.83
47.18
55.02
31.28
63.74
40.46
40.10
37.66
13.04
Short Term Borrowings
149.06
199.20
151.08
123.63
145.80
139.62
132.68
132.03
133.97
0.00
Short Term Provisions
0.80
1.59
1.41
5.50
6.25
9.61
7.83
5.54
3.60
11.02
Total Liabilities
1,130.35
1,071.40
885.59
524.05
511.53
483.48
424.98
423.91
427.93
398.12
Net Block
511.69
445.01
435.74
138.77
123.07
130.85
135.52
151.29
158.30
162.74
Gross Block
575.44
483.45
454.74
291.78
263.65
258.54
250.39
254.07
246.22
235.47
Accumulated Depreciation
63.75
38.44
19.00
153.00
140.58
127.69
114.87
102.78
87.92
72.73
Non Current Assets
676.88
624.20
510.54
209.87
195.76
195.93
197.66
201.92
208.83
200.37
Capital Work in Progress
104.47
126.09
19.60
40.48
41.47
34.56
35.69
27.15
27.26
30.25
Non Current Investment
30.21
30.21
30.20
7.39
7.39
7.36
7.36
7.39
7.39
7.39
Long Term Loans & Adv.
30.51
22.66
24.79
22.73
23.83
23.15
10.99
5.50
4.94
0.00
Other Non Current Assets
0.00
0.22
0.22
0.50
0.00
0.00
8.09
10.59
10.95
0.00
Current Assets
453.47
447.19
375.04
314.19
315.77
287.55
227.32
221.98
219.10
197.76
Current Investments
7.50
7.50
7.50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
192.65
175.09
135.11
126.66
113.40
93.42
92.17
92.42
79.92
71.93
Sundry Debtors
164.02
193.92
181.11
119.11
128.85
118.59
98.50
96.41
99.70
72.84
Cash & Bank
37.84
17.26
12.49
9.71
6.98
7.07
1.18
2.70
5.23
13.42
Other Current Assets
51.46
16.28
13.53
12.02
66.53
68.47
35.48
30.45
34.25
39.57
Short Term Loans & Adv.
31.77
37.15
25.30
46.68
45.23
43.01
25.66
18.75
21.29
20.21
Net Current Assets
126.49
80.27
89.45
46.18
20.63
-19.35
-35.66
-66.54
-60.62
101.59
Total Assets
1,130.35
1,071.39
885.58
524.06
511.53
483.48
424.98
423.90
427.93
398.13

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
69.91
11.27
38.68
44.83
13.17
48.77
25.83
49.34
32.33
15.23
PBT
20.34
13.93
67.19
42.00
24.72
34.55
15.78
0.83
4.92
-9.81
Adjustment
39.11
40.43
43.96
33.73
36.34
34.37
42.22
44.30
41.78
36.95
Changes in Working Capital
15.47
-40.02
-55.94
-19.17
-38.76
-16.82
-31.35
4.72
-13.98
-9.78
Cash after chg. in Working capital
74.91
14.35
55.20
56.56
22.30
52.11
26.65
49.85
32.72
17.35
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-5.01
-3.08
-16.52
-11.73
-9.13
-3.34
-0.82
-0.51
-0.38
-2.12
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-77.23
-116.29
-42.11
-19.86
-14.13
-9.84
-7.22
-5.21
-8.07
-23.34
Net Fixed Assets
-70.35
-135.20
-142.08
-27.14
-12.02
-7.02
-4.86
-7.74
-7.76
-23.27
Net Investments
0.00
-0.01
-30.31
0.12
-0.03
0.00
0.03
0.00
0.00
-0.21
Others
-6.88
18.92
130.28
7.16
-2.08
-2.82
-2.39
2.53
-0.31
0.14
Cash from Financing Activity
11.98
104.85
-0.09
-23.62
1.15
-38.96
-19.90
-43.70
-24.27
10.42
Net Cash Inflow / Outflow
4.66
-0.17
-3.51
1.35
0.19
-0.03
-1.28
0.42
-0.02
2.31
Opening Cash & Equivalents
3.29
3.44
6.97
0.81
0.62
0.65
1.93
1.51
1.53
11.11
Closing Cash & Equivalent
7.94
3.29
3.44
2.16
0.81
0.62
0.65
1.93
1.51
13.42

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
544.35
277.21
263.23
209.07
180.72
153.48
123.40
132.65
110.74
102.65
ROA
1.49%
1.23%
6.65%
5.23%
3.20%
5.89%
3.26%
0.60%
1.28%
-1.79%
ROE
3.48%
5.02%
22.34%
15.64%
11.24%
24.14%
15.92%
3.49%
7.56%
-9.82%
ROCE
3.99%
4.07%
15.98%
18.57%
15.75%
18.99%
15.58%
11.35%
11.46%
5.52%
Fixed Asset Turnover
1.26
1.13
1.57
1.86
1.82
1.87
1.86
1.82
1.67
1.28
Receivable days
97.96
129.34
93.22
87.45
94.81
83.45
75.67
78.78
78.35
93.43
Inventory Days
100.64
106.98
81.29
84.66
79.24
71.34
71.66
69.23
68.95
92.40
Payable days
76.53
82.06
67.03
85.01
92.70
82.14
88.22
97.55
91.06
97.22
Cash Conversion Cycle
122.08
154.27
107.48
87.10
81.35
72.66
59.11
50.45
56.25
88.61
Total Debt/Equity
0.33
1.30
0.82
0.98
1.17
1.55
2.13
2.93
3.23
3.47
Interest Cover
2.30
1.74
4.19
2.72
1.90
2.41
1.50
1.02
1.16
0.62

News Update:


  • USFDA completes inspection at Neuland Laboratories’ Hyderabad facility
    24th Jun 2019, 09:37 AM

    The inspection has been completed with five observations given under form 483

    Read More
  • Neuland Laboratories - Quarterly Results
    16th May 2019, 18:01 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.